Annual Retained Earnings
-$428.28 M
-$22.55 M-5.56%
December 31, 2023
Summary
- As of February 7, 2025, CYCC annual retained earnings is -$428.28 million, with the most recent change of -$22.55 million (-5.56%) on December 31, 2023.
- During the last 3 years, CYCC annual retained earnings has fallen by -$62.21 million (-16.99%).
- CYCC annual retained earnings is now -1368.08% below its all-time high of -$29.17 million, reached on December 31, 2000.
Performance
CYCC Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$436.44 M
-$1.96 M-0.45%
September 30, 2024
Summary
- As of February 7, 2025, CYCC quarterly retained earnings is -$436.44 million, with the most recent change of -$1.96 million (-0.45%) on September 30, 2024.
- Over the past year, CYCC quarterly retained earnings has dropped by -$8.16 million (-1.91%).
- CYCC quarterly retained earnings is now -404.00% below its all-time high of -$86.59 million, reached on December 31, 2003.
Performance
CYCC Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
CYCC Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.6% | -1.9% |
| 3 y3 years | -17.0% | -5.9% |
| 5 y5 years | -22.4% | -5.9% |
CYCC Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -11.4% | at low | -13.5% | at low |
| 5 y | 5-year | -19.8% | at low | -22.0% | at low |
| alltime | all time | -1368.1% | at low | -404.0% | at low |
Cyclacel Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$436.44 M(+0.5%) |
| Jun 2024 | - | -$434.49 M(+0.8%) |
| Mar 2024 | - | -$431.23 M(+0.7%) |
| Dec 2023 | -$428.28 M(+5.6%) | -$428.28 M(+1.2%) |
| Sep 2023 | - | -$423.01 M(+1.3%) |
| Jun 2023 | - | -$417.41 M(+1.3%) |
| Mar 2023 | - | -$411.96 M(+1.5%) |
| Dec 2022 | -$405.73 M(+5.5%) | -$405.73 M(+1.8%) |
| Sep 2022 | - | -$398.74 M(+1.3%) |
| Jun 2022 | - | -$393.64 M(+1.2%) |
| Mar 2022 | - | -$389.07 M(+1.2%) |
| Dec 2021 | -$384.53 M(+5.0%) | -$384.53 M(+1.3%) |
| Sep 2021 | - | -$379.66 M(+1.3%) |
| Jun 2021 | - | -$374.68 M(+1.4%) |
| Mar 2021 | - | -$369.55 M(+1.0%) |
| Dec 2020 | -$366.07 M(+2.4%) | -$366.07 M(+0.8%) |
| Sep 2020 | - | -$363.27 M(+0.6%) |
| Jun 2020 | - | -$361.01 M(+0.6%) |
| Mar 2020 | - | -$358.85 M(+0.3%) |
| Dec 2019 | -$357.63 M(+2.2%) | -$357.63 M(+0.6%) |
| Sep 2019 | - | -$355.32 M(+0.5%) |
| Jun 2019 | - | -$353.42 M(+0.5%) |
| Mar 2019 | - | -$351.64 M(+0.5%) |
| Dec 2018 | -$349.80 M(+2.1%) | -$349.80 M(+0.6%) |
| Sep 2018 | - | -$347.78 M(+0.6%) |
| Jun 2018 | - | -$345.71 M(+0.5%) |
| Mar 2018 | - | -$343.86 M(+0.4%) |
| Dec 2017 | -$342.51 M(+2.2%) | -$342.51 M(+0.6%) |
| Sep 2017 | - | -$340.63 M(+0.5%) |
| Jun 2017 | - | -$338.78 M(+0.6%) |
| Mar 2017 | - | -$336.59 M(+0.5%) |
| Dec 2016 | -$335.04 M(+3.7%) | -$335.04 M(+0.9%) |
| Sep 2016 | - | -$332.20 M(+0.9%) |
| Jun 2016 | - | -$329.25 M(+0.9%) |
| Mar 2016 | - | -$326.29 M(+1.0%) |
| Dec 2015 | -$323.16 M(+4.6%) | -$323.16 M(+1.1%) |
| Sep 2015 | - | -$319.79 M(+0.9%) |
| Jun 2015 | - | -$317.08 M(+1.1%) |
| Mar 2015 | - | -$313.73 M(+1.6%) |
| Dec 2014 | -$308.82 M(+6.7%) | -$308.82 M(+1.6%) |
| Sep 2014 | - | -$304.02 M(+1.6%) |
| Jun 2014 | - | -$299.11 M(+1.6%) |
| Mar 2014 | - | -$294.30 M(+1.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2013 | -$289.43 M(+7.1%) | -$289.43 M(+1.2%) |
| Sep 2013 | - | -$285.87 M(+2.0%) |
| Jun 2013 | - | -$280.21 M(-0.5%) |
| Mar 2013 | - | -$281.70 M(+4.2%) |
| Dec 2012 | -$270.25 M(+5.1%) | -$270.25 M(+1.8%) |
| Sep 2012 | - | -$265.49 M(+0.7%) |
| Jun 2012 | - | -$263.60 M(+1.4%) |
| Mar 2012 | - | -$260.02 M(+1.1%) |
| Dec 2011 | -$257.06 M(+6.3%) | -$257.06 M(+1.4%) |
| Sep 2011 | - | -$253.41 M(+1.4%) |
| Jun 2011 | - | -$249.96 M(+1.4%) |
| Mar 2011 | - | -$246.41 M(+1.9%) |
| Dec 2010 | -$241.82 M(+8.8%) | -$241.82 M(+1.6%) |
| Sep 2010 | - | -$238.05 M(+1.6%) |
| Jun 2010 | - | -$234.24 M(+2.8%) |
| Mar 2010 | - | -$227.81 M(+2.5%) |
| Dec 2009 | -$222.28 M(+9.7%) | -$222.28 M(+2.0%) |
| Sep 2009 | - | -$217.95 M(+1.5%) |
| Jun 2009 | - | -$214.82 M(+3.4%) |
| Mar 2009 | - | -$207.78 M(+2.5%) |
| Dec 2008 | -$202.72 M(+24.9%) | -$202.72 M(+4.1%) |
| Sep 2008 | - | -$194.77 M(+10.0%) |
| Jun 2008 | - | -$177.13 M(+5.1%) |
| Mar 2008 | - | -$168.58 M(+3.9%) |
| Dec 2007 | -$162.33 M(+17.4%) | -$162.33 M(+7.5%) |
| Sep 2007 | - | -$150.98 M(+2.9%) |
| Jun 2007 | - | -$146.76 M(+2.5%) |
| Mar 2007 | - | -$143.17 M(+3.5%) |
| Dec 2006 | -$138.28 M(+26.8%) | -$138.28 M(+4.2%) |
| Sep 2006 | - | -$132.74 M(+4.3%) |
| Jun 2006 | - | -$127.31 M(+5.8%) |
| Mar 2006 | - | -$120.37 M(+10.4%) |
| Dec 2005 | -$109.02 M(-13.6%) | -$109.02 M(-28.3%) |
| Sep 2005 | - | -$152.01 M(+9.1%) |
| Jun 2005 | - | -$139.37 M(+4.4%) |
| Mar 2005 | - | -$133.47 M(+5.8%) |
| Dec 2004 | -$126.18 M(+45.7%) | -$126.18 M(+7.1%) |
| Sep 2004 | - | -$117.80 M(+6.2%) |
| Jun 2004 | - | -$110.97 M(+5.8%) |
| Mar 2004 | - | -$104.88 M(+21.1%) |
| Dec 2003 | -$86.59 M(+27.1%) | -$86.59 M |
| Dec 2002 | -$68.14 M(+40.0%) | - |
| Dec 2001 | -$48.69 M(+66.9%) | - |
| Dec 2000 | -$29.17 M | - |
FAQ
- What is Cyclacel Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Cyclacel Pharmaceuticals?
- What is Cyclacel Pharmaceuticals annual retained earnings year-on-year change?
- What is Cyclacel Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Cyclacel Pharmaceuticals?
- What is Cyclacel Pharmaceuticals quarterly retained earnings year-on-year change?
What is Cyclacel Pharmaceuticals annual retained earnings?
The current annual retained earnings of CYCC is -$428.28 M
What is the all time high annual retained earnings for Cyclacel Pharmaceuticals?
Cyclacel Pharmaceuticals all-time high annual retained earnings is -$29.17 M
What is Cyclacel Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, CYCC annual retained earnings has changed by -$22.55 M (-5.56%)
What is Cyclacel Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of CYCC is -$436.44 M
What is the all time high quarterly retained earnings for Cyclacel Pharmaceuticals?
Cyclacel Pharmaceuticals all-time high quarterly retained earnings is -$86.59 M
What is Cyclacel Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, CYCC quarterly retained earnings has changed by -$8.16 M (-1.91%)